Prolonged Cotrimoxazole Prophylaxis Has No Impact on Child Growth in the First Two Years of Life: Findings from a Randomized Controlled Trial in Botswana.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 35351531.
- Also identified by DOI 10.1016/j.jpeds.2022.03.031 and PMC identifier 9233016.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We investigated the impact of prolonged cotrimoxazole prophylaxis on growth in 2848 HIV-exposed uninfected children enrolled in the Mpepu study, a randomized, placebo-controlled trial in Botswana. No significant differences in mean weight-for-age, length-for-age, or weight-for-length z scores between placebo and cotrimoxazole arms were observed overall through 18 months.
Medical subject headings
- HIV Infections
- Trimethoprim, Sulfamethoxazole Drug Combination